Concepedia

Publication | Open Access

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial

252

Citations

17

References

2018

Year

Abstract

NCT01599754.

References

YearCitations

Page 1